Early day motion tabled by primary sponsor Daisy Cooper (Liberal Democrat), on Tuesday, 6 June 2023, in the House of Commons. It is signed by 18 members in total.
Measures to enable immunocompromised and immunosuppressed patients to live with covid-19
That this House regrets the continued failure of Government to protect people who have moderate to severe immune compromise from covid-19 infection, by failing to make Evusheld available on the NHS when it was at its most effective against covid strains; notes with alarm the disbandment of the Enhanced Protection Programme, Covid-19 Antivirals and Therapeutics Taskforce, ONS Covid-19 Infection Survey and the closure of Covid Medicine Delivery Units since 31 March 2023; deeply regrets that patients have had to cancel routine medical appointments and surgery in fear of potentially lethal covid infection; further regrets that many patients are entering a fourth year of shielding or social distancing, losing out on employment and opportunities; applauds the campaigning efforts of Evusheld for the UK and Forgotten Lives UK, and the many patient groups calling for action; further notes with alarm that the spring booster vaccination programme has not been adequately promoted; also notes with alarm new NHS advice that, from 27 June 2023, immunocompromised patients will no longer be automatically contacted by the NHS about treatments after reporting a positive covid result; notes the engagement of the National Institute for Health and Care Excellence with patient advocacy groups to accelerate access to effective drugs and treatments; and calls on the Government to urgently establish a vulnerable patients task force to accelerate access to effective drugs and treatments for immunocompromised patients and to develop a strategy to enable people who have moderate to severe immune compromise from covid-19 infection, to live with covid.
Secondary information
- Type
- Early day motion
- Reference
- 1270
- Session
- 2022-23
- Other sponsors
- John McDonnell
- Jim Shannon
- Sarah Olney
- Mohammad Yasin
- Richard Foord
- Subjects
- Medical treatments Coronavirus Immunosuppression Tixagevimab/cilgavimab
- Link
- View this Early day motion on edm.parliament.uk
Librarians' tools
- Timestamp
- 2023-07-14 11:08:56 +0100
- URI
- http://data.parliament.uk/edms/61005
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/edms/61005
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/edms/61005